Navigation Links
Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
Date:4/18/2008

Trial Marks Third Study in Company's STEALTH C Clinical Program to Evaluate

Nitazoxanide in the Treatment of Chronic Hepatitis C

TAMPA, Fla., April 18 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, today announced that it has begun enrolling patients in a U.S. clinical trial to evaluate nitazoxanide for the treatment of chronic hepatitis C. Preliminary data from the study is expected in the second half of 2008.

The study, STEALTH C-3 (Studies to Evaluate Alinia for Treatment of Hepatitis C), is a Phase II randomized, double-blind, placebo-controlled clinical trial designed to evaluate the safety and efficacy of nitazoxanide in combination with peginterferon alpha-2a (Pegasys(R), Roche) and ribavirin (Copegus(R), Roche) in treatment naive patients with chronic hepatitis C infected with genotype 1.

The primary objective of STEALTH C-3 is to evaluate sustained virologic response (SVR) with a treatment regimen of 4 weeks of nitazoxanide lead-in therapy followed by 48 weeks of standard of care plus nitazoxanide versus 4 weeks of placebo lead-in followed by 48 weeks of standard of care and placebo. The trial will enroll 60 patients at 15 centers in the U.S.

"Earlier clinical studies in patients with chronic hepatitis C infected with genotype 4 have shown that nitazoxanide improves virologic response rates when used in combination with standard of care," said Dr. Emmet B. Keeffe, Chief Medical Officer of Romark. "This study and our ongoing STEALTH C-2 trial, are designed to evaluate the effect of treatment with nitazoxanide plus standard of care in patients with genotype 1. Future clinical trials will explore new combinations and treatment durations, including current and emerging HCV therapies."

STEALTH C Clinical Development Program

STEALTH C-3 is the latest in a series of clinical trials aimed at gaining a broad understanding of how nitazoxanide may benefit patients with chronic
'/>"/>

SOURCE Romark Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Romark Laboratories Raises $18 Million in Institutional Financing
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
4. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
5. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
6. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
7. BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety
8. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
9. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
10. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
11. Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... The Impact of Healthcare Reform (PPACA) On ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html The "Patient Protection and ... that affects virtually every aspect of health care, ... take effect now. IVD manufacturers who have different ...
(Date:8/20/2014)... DUBLIN , Aug. 20, 2014 ... addition of the "Global Biosimilars/Follow-on-Biologics Market (Technology, ... 2013 - 2020" report to their offering. ... biosimilars/follow-on-biologics market (types, applications and geography) - Size, ... Research, Report, Opportunities, Segmentation and Forecast, 2013 - ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2
... CITY , April 28 Sonic Innovations, Inc. (Sonic), the ... conducting ongoing training events for government clinicians.  The company has just completed ... San Diego, California and April 25 through 27 in ... 3 through 5 in Salt Lake City, Utah , ...
... April 28 The Wireless-Life Sciences Alliance ... its Wireless Health Commercialization Day on May 13, 2010 ... Convergence Summit, a three-day conference sponsored by the premier trade ... wireless communications technologies. The conference is scheduled for May ...
Cached Medicine Technology:Sonic Innovations Conducts National Training Events for Government Clinicians 2Sonic Innovations Conducts National Training Events for Government Clinicians 3Thought Leaders Shaping the Emerging Wireless Life Science Space to Share Vision and Insights at WLSA Convergence Summit 2Thought Leaders Shaping the Emerging Wireless Life Science Space to Share Vision and Insights at WLSA Convergence Summit 3Thought Leaders Shaping the Emerging Wireless Life Science Space to Share Vision and Insights at WLSA Convergence Summit 4
(Date:8/21/2014)... AttorneyOne.com, a recognized authority on law, ... from the FDA on Dianeal Low Calcium (2.5mEq/L) ... on August 15, that two lots of Dianeal Low ... (Ambu-Flex II), by Baxter International Inc., are recalled ... , The reason for the recall is the presence ...
(Date:8/21/2014)... The employees of Pharmica Consulting ... Pennsylvania on Thursday, August 7th to spend their day ... for different ways that Pharmica could get involved with ... Consulting. “When we heard that we could help preserve ... at the opportunity.” , Pharmica spent their day tackling ...
(Date:8/21/2014)... She was 12 years old when the unthinkable ... surgery to correct her frequent headaches failed. , In ... Strom-Stewart shares her journey of overcoming devastating obstacles involving dual ... miscarriage of justice for years. , “My faith in ... into the light,” Strom-Stewart said. “But it took me more ...
(Date:8/21/2014)... The rising numbers of teen drug and alcohol abuse ... years, countless lives have been lost due to teenager addiction. ... helpline was established to provide a valuable source of information ... overcome their youth substance abuse issues. , ... 257-4053, parents and their teens can speak immediately to a ...
(Date:8/21/2014)... 21, 2014 Michael E. Steuer , ... roots back to the Bluff City with recent philanthropy at ... those in the United States,” says friend and Rabbi David ... outreach programs, such as providing in-house for the needy and ... by serving in the local synagogue. And to remain close ...
Breaking Medicine News(10 mins):Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Pharmica Spends the Day Helping to Preserve Washington Crossing Historic Park 2Health News:The Dramatic, Uplifting Story from a Brain Injured Woman 2Health News:Troubled Teens in Boynton Beach, FL Turn to Helpline for Valuable Assistance 2
... Income in Company History, BELLEVUE, Wash., Feb. 6 ... provider of health, beauty, vision, and,pharmacy products, today announced ... ended December 30, 2007. The company reported,quarterly net sales ... $0.00,per share. The company achieved record gross margins in ...
... of Mobility Program Helps Eden Home Resident regain mobility and,Be ... is a "sweetheart with a sweet tooth" say his friends ... a borrowed power wheelchair,from delivering mail at the facility where ... self-professed "chocoholic." To keep him on the,go, The SCOOTER Store ...
... 6 The Juvenile,Products Manufacturers Association (JPMA), which ... United States, stands by the,scientific research indicating that ... to fall victim to scare tactics., There ... Bisphenol-A, a,material used to make tough, shatter-resistant polycarbonate ...
... Va., Feb. 6 The HealthCentral,Network, Inc. ... accomplished dermatologist, cosmetic surgeon and author, is,joining the ... Sundaram is the author of Face Value: The ... It [Rodale], which was honored by,the National Press ...
... Medical,Innovations, Inc. (Amex: IMA ), a leading ... consumer and professional markets, announced,today that it will ... being held February 11 through 13, 2008 at ... Zwanziger, Chief Executive Officer, and Jon Russell,Vice President, ...
... saves lives. It saves money. And it,s time., ... of the,growing momentum for electronic prescribing (e-prescribing), Health ... before the,Senate Finance Committee that e-prescribing standards and ... adopt the technology in Medicare., When questioned ...
Cached Medicine News:Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 2Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 3Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 4Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 5Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 6Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 7Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 8Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 9Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 10Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 11Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 12Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 13Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 14Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 15Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 16Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 17Health News:The SCOOTER Store Donates Power Wheelchair to New Braunfels Car Crash Victim 2Health News:JPMA on the Safety of Baby Bottles 2Health News:Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com 2Health News:Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com 3Health News:Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008 2Health News:PCMA Applauds Secretary Leavitt's Support for Requiring E-Prescribing in Medicare 2Health News:PCMA Applauds Secretary Leavitt's Support for Requiring E-Prescribing in Medicare 3
... was designed with thinner, long jaws ... IOL through a tunnel or clear ... the lens securely, but will not ... wide enough to allow the lens ...
Titanium. Curved 18 mm shafts with 1.5 wide grasping tip. Flat, serrated cross action handle with dull finish....
45 degree. Angled shafts. Tip to angle length: 11.5 mm. Stops in handle designed to prevent "over folding". Manufactured in titanium....
Excellent for inserting rigid or flexible implants. Rounded tips provide excellent purchase of the optic...
Medicine Products: